BRD4 and cancer: The PROTAC degrader ARV-825, which effectively degrades bromodomain-containing protein 4 (BRD4) via E3 ligase cereblon (CRBN)-mediated ubiquitination, exhibits potent efficacy against several cancer types, including PDAC (Minko, 2020; Saraswat et al., 2020).